CYDX (Cyduct Diagnostics) Interest Expense: $ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cyduct Diagnostics Interest Expense?

Cyduct Diagnostics CYDX Interest Expense is $ Mil as of . 20.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cyduct Diagnostics's interest expense for the three months ended in . 20 was $ 0.00 Mil. Cyduct Diagnostics does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cyduct Diagnostics's Operating Income for the three months ended in . 20 was $ 0.00 Mil. Cyduct Diagnostics's Interest Expense for the three months ended in . 20 was $ 0.00 Mil. Cyduct Diagnostics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cyduct Diagnostics  (OTCPK:CYDX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cyduct Diagnostics's Interest Expense for the three months ended in . 20 was $0.00 Mil. Its Operating Income for the three months ended in . 20 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in . 20 was $0.00 Mil.

Cyduct Diagnostics's Interest Coverage for the quarter that ended in . 20 is calculated as

Cyduct Diagnostics had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Cyduct Diagnostics Interest Expense Historical Data

* Premium members only.

The historical data trend for Cyduct Diagnostics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyduct Diagnostics Interest Expense Chart

Cyduct Diagnostics Annual Data
Trend
Interest Expense

Cyduct Diagnostics Quarterly Data
Interest Expense

Cyduct Diagnostics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $ Mil mean?
Cyduct Diagnostics (CYDX) has a Interest Expense of $ Mil as of . 20. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cyduct Diagnostics and its competitors.
Is Cyduct Diagnostics' Interest Expense too high?
Cyduct Diagnostics' current Interest Expense is $ Mil.
How does Cyduct Diagnostics' Interest Expense compare to SECI and QTXB?
Cyduct Diagnostics' Interest Expense of $ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cyduct Diagnostics and its competitors. Cyduct Diagnostics's current Interest Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyduct Diagnostics stock overvalued right now?
Cyduct Diagnostics (CYDX) has a current Interest Expense of $ Mil. The current Interest Expense is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Cyduct Diagnostics (CYDX), the current Interest Expense is $ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cyduct Diagnostics Business Description

Address 1698 Post Road East, Suite 1A, Westport, CT, USA, 06880
Cyduct Diagnostics Inc is a clinical-stage diagnostic company. It focuses on creating and enhancing a portfolio of technologies and assets based on the early assessment and detection of Breast Cancer. Its technology platform of MammoView devices is a single-use, high-margin product that assesses, screens, detects, monitors, and facilitates the treatment of identifiable changes that distinguish variations in breast health. The company markets these products under its Solos Endoscopy brand, along with a line of branded surgical instruments, manufactured by third parties to its design specifications, mainly endoscopes and hand-held surgical instruments for the minimally invasive surgery market.